Jula Veerapong
Department of Surgery
University of California
Jula Veerapong has not added Biography.
If you are Jula Veerapong and would like to personalize this page please email our Author Liaison for assistance.
Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Annals of surgical oncology Jul, 2019 | Pubmed ID: 31065960
Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis.
Gastroenterology research Jun, 2018 | Pubmed ID: 29915638
Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
Annals of surgical oncology May, 2019 | Pubmed ID: 30815802
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
Annals of surgical oncology Jul, 2019 | Pubmed ID: 31016486
Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer.
Annals of surgical oncology Oct, 2019 | Pubmed ID: 31190209
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Jan, 2020 | Pubmed ID: 31428960
Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
American journal of surgery Mar, 2020 | Pubmed ID: 31558307
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
Annals of surgical oncology Mar, 2020 | Pubmed ID: 31659645
Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Jan, 2020 | Pubmed ID: 31745888
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.
Clinical colorectal cancer Mar, 2020 | Pubmed ID: 31974019
Detection of Mesenteric Tumor Using Dynamic Contrast Enhanced MRI.
Annals of surgical oncology Jul, 2020 | Pubmed ID: 32157527
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review.
Journal of clinical medicine Mar, 2020 | Pubmed ID: 32164300
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
Annals of surgical oncology Dec, 2020 | Pubmed ID: 32318945
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC.
Annals of surgical oncology Dec, 2020 | Pubmed ID: 32378087
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
The Journal of surgical research Nov, 2020 | Pubmed ID: 32622162
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.
Annals of surgical oncology Dec, 2020 | Pubmed ID: 32696303
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
Annals of surgical oncology Sep, 2020 | Pubmed ID: 32767050
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Dec, 2020 | Pubmed ID: 32826114
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative.
World journal of gastrointestinal oncology Jul, 2020 | Pubmed ID: 32864043
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Dec, 2020 | Pubmed ID: 32873454
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
Journal of surgical oncology Jan, 2021 | Pubmed ID: 33002202
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
Annals of surgical oncology Dec, 2020 | Pubmed ID: 33073341
Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
PloS one , 2020 | Pubmed ID: 33270763
HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease.
Gynecologic oncology Apr, 2021 | Pubmed ID: 33293046
A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms.
Annals of surgical oncology Aug, 2021 | Pubmed ID: 33415564
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies.
Surgical oncology Jun, 2021 | Pubmed ID: 33465587
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
Annals of surgical oncology Aug, 2021 | Pubmed ID: 33507449
The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Nov, 2021 | Pubmed ID: 33634422
Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.
Human pathology Jul, 2021 | Pubmed ID: 33905776
Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Feb, 2022 | Pubmed ID: 34506026
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
The Journal of surgical research Sep, 2022 | Pubmed ID: 35525209
Pregnancy-associated large pelvic desmoid tumor: A case report of fetal-protective strategies and fertility preservation.
Gynecologic oncology reports Feb, 2022 | Pubmed ID: 35531359
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery.
JAMA network open May, 2022 | Pubmed ID: 35612856
An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2022 | Pubmed ID: 36067351
Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial.
Journal of the American College of Surgeons Nov, 2022 | Pubmed ID: 36102565
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Dec, 2022 | Pubmed ID: 36258061
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
Annals of surgical oncology Oct, 2022 | Pubmed ID: 36305990
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Annals of surgical oncology Oct, 2022 | Pubmed ID: 36310315
ASO Visual Abstract: Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
Annals of surgical oncology Nov, 2022 | Pubmed ID: 36369408
ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Annals of surgical oncology Nov, 2022 | Pubmed ID: 36418799
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
Journal of surgical oncology Dec, 2022 | Pubmed ID: 36468401
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis.
Surgical endoscopy Dec, 2022 | Pubmed ID: 36477643
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved